Kyverna therapeutics to present at the leerink partners global biopharma conference

Emeryville, calif. , march 3, 2025 /prnewswire/ -- kyverna therapeutics, inc. (kyverna, nasdaq: kytx), a clinical-stage biopharmaceutical company focused on developing cell therapies for patients with autoimmune diseases, today announced that warner biddle, chief executive officer of kyverna, will present at the leerink partners global biopharma conference in miami, fl on monday, march 10, 2025, at 3:00 p.m.
KYTX Ratings Summary
KYTX Quant Ranking